Small interfering RNA: Discovery, pharmacology and clinical development—An introductory review

P Ranasinghe, ML Addison, JW Dear… - British Journal of …, 2023 - Wiley Online Library
Post‐transcriptional gene silencing targets and degrades mRNA transcripts, silencing the
expression of specific genes. RNA interference technology, using synthetic structurally well …

The renin–angiotensin system biomolecular cascade: a 2022 update of newer insights and concepts

CM Ferrario, L Groban, H Wang, X Sun… - Kidney international …, 2022 - Elsevier
A large body of evidence implicates the renin–angiotensin system in the pathogenesis of
cardiovascular disease. However, not everyone understands that the magnitude of the risk …

Small Interfering RNA Therapeutics in Hypertension: A Viewpoint on Vasopressor and Vasopressor‐Sparing Strategies for Counteracting Blood Pressure Lowering by …

P Ranasinghe, ML Addison… - Journal of the American …, 2022 - Am Heart Assoc
Hypertension is an extremely common noncom-municable condition affecting an estimated
1.3 billion adults (aged 30–79 years) worldwide and with a prevalence that has doubled …

Hypertension: Current trends and future perspectives

PG Hunter, FA Chapman… - British Journal of Clinical …, 2021 - Wiley Online Library
Hypertension is a significant and increasing global health issue. It is a leading cause of
cardiovascular disease and premature death worldwide due to its effects on end organs …

Angiotensinogen: more than its downstream products: evidence from population studies and novel therapeutics

T Kahlon, S Carlisle, D Otero Mostacero, N Williams… - Heart Failure, 2022 - jacc.org
The renin-angiotensin-aldosterone system (RAAS) is a well-defined pathway playing a key
role in maintaining circulatory homeostasis. Abnormal activation of RAAS contributes to …

The Angiotensin-(1–12)/Chymase axis as an alternate component of the tissue renin angiotensin system

CM Ferrario, L Groban, H Wang, CP Cheng… - Molecular and cellular …, 2021 - Elsevier
The identification of an alternate extended form of angiotensin I composed of the first twelve
amino acids at the N-terminal of angiotensinogen has generated new knowledge of the …

COVID-19 and other adult vaccines can drive global disease prevention

DB Agus, A Nguyen, J Bell - The Lancet, 2023 - thelancet.com
The COVID-19 pandemic has led to a renewed recognition of the importance of disease
prevention and public health globally. The progress in COVID-19 vaccine technology is a …

Future treatments in hypertension: Can we meet the unmet needs of patients?

M Kanbay, S Copur, C Tanriover, D Ucku… - European Journal of …, 2023 - Elsevier
The prevalence of arterial hypertension is approximately 47% in the United States and 55%
in Europe. Multiple different medical therapies are used to treat hypertension including …

Challenges in the development of novel therapies, vaccines and siRNAs for the treatment of hypertension

H Nakagami - Hypertension Research, 2023 - nature.com
Hypertension is a common noncommunicable condition estimated to affect over one billion
adults worldwide, with a prevalence that has doubled over the past 20 years [1]. From 2012 …

Immunoneutralization of human angiotensin-(1-12) with a monoclonal antibody in a humanized model of hypertension

CM Ferrario, JL VonCannon, J Zhang, JP Figueroa… - Peptides, 2022 - Elsevier
We engineered a monoclonal antibody (mAb) against the human C-terminus of angiotensin-
(1–12)[h-Ang-(1–12)] and performed a biochemical characterization in concert with direct in …